Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -29.569% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a) Cc1cccc(OCC(=O)Nc2ccncc2)c1
b) Cc1ccc(N(Cc2ccccc2)C(=O)c2ccc(F)cc2)cc1
c) CCOC(=O)c1c[nH][nH]c1=O
d) CC(C)[C@H](NC(=O)N1CCn2c1nc1ccccc12)C(=O)NC1CC1
Answer: d. CC(C)[C@H](NC(=O)N1CCn2c1nc1ccccc12)C(=O)NC1CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)[C@H](NC(=O)N1CCn2c1nc1ccccc12)C(=O)NC1CC1
CC(C)[C@H](NC(=O)N1CCn2c1nc1ccccc12)C(=O)NC1CC1
N-[(2S)-1-(cyclopropylamino)-3-methyl-1-oxobutan-2-yl]-1,2-dihydroimidazo[1,2-a]benzimidazole-3-carboxamide